ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
68 967,33
-0,43%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Passage Bio Inc (PASG)

  7. Passage Bio Inc (PASG) Actualités

PASG

Passage Bio (PASG)

Passage Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PASG
DateHeureSourceTitreSymboleSociété
23/05/202422h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
22/05/202422h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
21/05/202414h00GlobeNewswire Inc.Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship AwardNASDAQ:PASGPassage Bio Inc
14/05/202414h15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PASGPassage Bio Inc
14/05/202413h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PASGPassage Bio Inc
14/05/202413h00GlobeNewswire Inc.Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
22/04/202413h00GlobeNewswire Inc.Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:PASGPassage Bio Inc
05/03/202413h00GlobeNewswire Inc.Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship ProgramNASDAQ:PASGPassage Bio Inc
04/03/202423h22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PASGPassage Bio Inc
04/03/202422h09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PASGPassage Bio Inc
04/03/202413h15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PASGPassage Bio Inc
04/03/202413h00GlobeNewswire Inc.Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
27/02/202413h00GlobeNewswire Inc.Passage Bio to Participate in Upcoming Investor ConferencesNASDAQ:PASGPassage Bio Inc
14/02/202415h21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PASGPassage Bio Inc
20/12/202313h00GlobeNewswire Inc.Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic PrioritiesNASDAQ:PASGPassage Bio Inc
17/11/202322h30GlobeNewswire Inc.Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:PASGPassage Bio Inc
13/11/202313h00GlobeNewswire Inc.Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
30/10/202312h00GlobeNewswire Inc.Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology ConferenceNASDAQ:PASGPassage Bio Inc
20/10/202322h30GlobeNewswire Inc.Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PASGPassage Bio Inc
25/09/202313h00GlobeNewswire Inc.Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines ConferenceNASDAQ:PASGPassage Bio Inc
07/08/202313h15GlobeNewswire Inc.Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
07/08/202313h00GlobeNewswire Inc.Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 StudyNASDAQ:PASGPassage Bio Inc
01/08/202313h00GlobeNewswire Inc.Passage Bio to Participate in Upcoming Investor ConferencesNASDAQ:PASGPassage Bio Inc
31/07/202323h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
31/07/202313h00GlobeNewswire Inc.Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of DirectorsNASDAQ:PASGPassage Bio Inc
29/06/202322h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PASGPassage Bio Inc
29/06/202322h37Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PASGPassage Bio Inc
05/06/202313h00GlobeNewswire Inc.Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare ConferenceNASDAQ:PASGPassage Bio Inc
26/05/202322h34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PASGPassage Bio Inc
11/05/202313h13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PASGPassage Bio Inc
 Showing the most relevant articles for your search:NASDAQ:PASG

Dernières Valeurs Consultées

USI
USTECH100
US Tech 100
EU
GLE
Societe Generale
EU
VIV
Vivendi
EU
VK
Vallourec
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
EU
EN
Bouygues
EU
ML
Michelin
NASDAQ
AMZN
Amazon.com
EU
AF
Air FranceKLM
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés